ERBB2 and cancer: We constructed a HER2 IgY-SWNT complex by directly functionalizing SWNTs with the anti-HER2 IgY antibody through covalent bonding, explored the Raman and NIR optical properties of the complex, and tested its feasibility for detection and selective destruction of cancer cells.